Mouwasat Medical Services Company SJSC
SAU:4002
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
104.4
142.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Mouwasat Medical Services Company SJSC
Mouwasat Medical Services Company SJSC
Cost of Revenue
Mouwasat Medical Services Company SJSC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mouwasat Medical Services Company SJSC
SAU:4002
|
Cost of Revenue
-ď·Ľ1.5B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-12%
|
|
|
Dallah Healthcare Company SJSC
SAU:4004
|
Cost of Revenue
-ď·Ľ1.9B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-15%
|
|
|
National Medical Care Company JSC
SAU:4005
|
Cost of Revenue
-ď·Ľ753.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
A
|
Al Hammadi Holding Co
SAU:4007
|
Cost of Revenue
-ď·Ľ744.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-11%
|
|
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
Cost of Revenue
-ď·Ľ6.2B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
Cost of Revenue
-ď·Ľ1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Mouwasat Medical Services Company SJSC
Glance View
Mouwasat Medical Services Co. engages in the ownership, acquisition, management, operation, and maintenance of hospitals, medical centers, medicine warehouses, pharmacies and wholesale of medical equipment and drugs. The company is headquartered in Dammam, Eastern Province. The company went IPO on 2009-09-02. The firm operates in two segments: medical services segment, which includes Inpatient and outpatient services and pharmaceuticals segments. The firm also operates specialize centers, which include Long term care, rehabilitation center, stroke unit, cardiology center, nuclear medicine, fertility, skin care and badana clinic, among others. The firm operates approximately 9 branches and The Company’s subsidiaries includes Eastern Medical Services Company Limited and Jeddah Doctors Company.
See Also
What is Mouwasat Medical Services Company SJSC's Cost of Revenue?
Cost of Revenue
-1.5B
SAR
Based on the financial report for Jun 30, 2024, Mouwasat Medical Services Company SJSC's Cost of Revenue amounts to -1.5B SAR.
What is Mouwasat Medical Services Company SJSC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-12%
Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Mouwasat Medical Services Company SJSC have been -10% over the past three years , -9% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
